Scientists have achieved the first DNA-free CRISPR gene editing in raspberries, reaching 19% efficiency and opening the door to faster breeding of firmer, more resilient berries — though regenerating ...

CRSP is a speculative buy for aggressive investors, driven by the commercial launch and multibillion-dollar potential of ...

CRISPR is a technology that can be used to edit genes and, as such, will likely change the world. The essence of CRISPR is simple: it’s a way of finding a specific bit of DNA inside a cell. After that ...

CRISPR/Cas9 allows for precise modifications to the genome, including knock-ins, knockouts, transcriptional activation and repression, and base conversions. This technology has been used to treat ...

Albino cane toads created using gene-editing technology reveal that albino animals face competitive disadvantages going far ...

A new generation of CRISPR technology developed at UNSW Sydney offers a safer path to treating genetic diseases like sickle ...

AI and machine learning are revolutionizing CRISPR technology, enhancing precision and efficiency in gene editing, paving the way for breakthroughs in genetic research and therapy.

TheCRISPR Technology Market Report 2024, with Profiles of Major Players Agilent Technologies, Beam Therapeutics, Caribou Biosciences, Crispr Therapeutics, Danaher, Genscript, Lonza and More ...

NtRON Bio announced today, following its recent U.S. patent application related to colorectal cancer using the IMPA™ phage engineering technology, it has now completed the filing of two patents for a ...

Shares of CRISPR Therapeutics CRSP have rallied 41.4% in the past three months, driven by encouraging data from a study of ...

Ace hedge fund manager Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made a few but notable portfolio adjustments on ...